NCT02137343 2016-04-04
RILOMET-2
Amgen
Phase 3 Terminated
Clinical Trials
4 trialsNCT01791374 2016-02-29
Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ
Amgen
Phase 1 Completed
NCT01697072 2016-02-09
RILOMET-1
Amgen
Phase 3 Terminated
NCT00719550 2013-12-05
AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer
Amgen
Phase 1/2 Completed